Press-release for stocks for IPHA

Prices are updated after-hours

symbols : IPHA crawled time : 09:00

save search

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -0.28% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -0.18% | O: -0.32% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -5.38% | O: -3.85% H: 1.2% C: 0.8%
iph45 pharma drug candidate antibody preclinical

Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published: 2024-04-09 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| 0.0% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 0.26% | O: -0.38% H: 0.95% C: 0.83%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -1.2% | O: 2.57% H: 1.81% C: 1.81%
pharma conference

Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -0.92% | O: 0.14% H: 0.24% C: 0.24%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 0.26% | O: 0.3% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -1.6% | O: -4.51% H: 4.25% C: 0.96%
pharma business year update financial results

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -1.81% | O: 0.23% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -1.6% | O: -2.4% H: 3.69% C: 3.28%
pharma conference year financial results

Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -6.21% | O: 1.62% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -5.22% | O: 1.12% H: 0.93% C: 0.77%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -11.51% | O: 6.47% H: 3.65% C: -2.36%
pharma

Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 4.55% | O: 0.68% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| 8.37% | O: 6.61% H: 9.39% C: 6.61%
pharma business update financial results

Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR’579 / IPH6101 in R/R AML
Published: 2023-05-26 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -10.56% | O: 0.5% H: 1.67% C: 1.67%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -10.67% | O: -0.21% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -14.88% | O: 1.04% H: 1.54% C: -0.51%
iph6101 pharma cell aml sanofi

Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
Published: 2023-05-10 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -13.84% | O: -1.75% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -19.34% | O: -2.46% H: 2.18% C: -1.34%
pharma business update financial results

Innate Pharma Announces Conference Call and Webcast for Q1 Business Update
Published: 2023-05-03 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -11.15% | O: 0.71% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -11.51% | O: -0.56% H: 7.08% C: 4.55%
pharma conference business update

Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting
Published: 2023-05-03 (Crawled : 09:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -11.15% | O: 0.71% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -11.51% | O: -0.56% H: 7.08% C: 4.55%
pharma asco meeting

Innate Pharma to Participate in Upcoming April 2023 Investor Conference
Published: 2023-04-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -14.72% | O: 1.61% H: 0.0% C: -0.45%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -14.74% | O: 1.46% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -17.86% | O: -0.17% H: 2.34% C: 0.0%
pharma conference

Innate Pharma Files Its 2022 Universal Registration Document (Document d’enregistrement universel) and 2022 Annual Report on Form 20-F
Published: 2023-04-06 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -14.55% | O: 1.36% H: 2.91% C: 2.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -14.07% | O: 1.13% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -22.78% | O: 2.33% H: 3.37% C: -2.91%
pharma report universal

Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published: 2023-03-13 (Crawled : 09:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology

| -10.71% | O: -0.02% H: 1.44% C: -0.51%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -0.67% | O: -0.81% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -16.47% | O: 2.21% H: 4.65% C: -1.66%
pharma update

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
Published: 2022-11-07 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| 7.92% | O: -2.01% H: 0.88% C: 0.88%
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology

| 12.23% | O: 0.91% H: 1.82% C: 1.43%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 9.57% | O: -0.46% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| 13.36% | O: -1.38% H: 2.8% C: 1.87%
pharma conference update

Innate Pharma to Participate in Upcoming Investor Conferences - November 02, 2022
Published: 2022-11-02 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| 5.38% | O: -2.21% H: 0.0% C: -0.14%
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology

| 18.54% | O: 4.84% H: 4.18% C: 1.48%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 9.83% | O: 0.07% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| 12.33% | O: -5.48% H: 2.42% C: -0.97%
pharma

Innate Pharma to Participate in Upcoming Investor Conferences - May 11, 2022
Published: 2022-05-11 (Crawled : 09:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology

| 17.42% | O: -2.55% H: 2.32% C: -0.85%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -7.95% | O: -0.33% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -9.39% | O: 5.34% H: 1.75% C: -1.4%
pharma

Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
IPHYF | $2.65 104.6% 300

Health Technology

| -47.94% | O: -0.39% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -6.42% | O: -5.02% H: 5.6% C: 0.96%
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology

| 11.38% | O: 2.6% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -1.82% | O: 1.91% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690

Health Technology

| -52.23% | O: -1.27% H: 1.68% C: 0.5%
iph6101 blood trial phase 1 cancer phase 2

Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update
Published: 2021-11-09 (Crawled : 09:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M

Health Technology